Case Report

“Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?

Volume: 2 Number: 5 July 6, 2015
EN

“Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?

Abstract

We hereby describe a 46-year woman with nephrotic syndrome and new-onset breast cancer. This patient admitted to our hospital with peripheral edema and a mass in her right breast. Membranous glomerulonephritis (MGN) was the etiology of nephrotic syndrome. MGN has been reported in association with a wide variety of solid neoplastic diseases, although rarely occurs as a complication of breast carcinoma. We report a rare and a resistant case of MGN, who was concomitant diagnosed with breast cancer and there was no improvement in proteinuria although breast cancer was under-controlled with cheomotheraphy and surgery. 

Keywords

References

  1. Valcamonico F, Ferrari V, Simoncini E, Gregorini G, Vassalli L, Amoroso V., et al. Paraneoplastic Nephrotic Syndrome in Advanced Breast Cancer Patient. A Case Report. Tumori 2004; 90 (1): 154-156.
  2. Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11:297-306.
  3. Pai P, Bone JM, McDicken I, Bell GM. Solid tumour and glomerulopathy. Q J Med 1996; 89:361-367.
  4. Ozawa T, Pluss R, Lacher J, Boadecker E, Guggenheim S, Hammond W., et al. Endogenous immune complex nephropathy associated with malignancy: studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterisation of tumour specific antigen and antibody and circulating immune complexes. Q J Med 1975; 44:523-541.
  5. Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD. The Nephrotic Syndrome Associated with Neoplasia: An Unusual Paraneoplastic Syndrome Report of a Case and Review of the Literature. Am J Med 1976; 60:1026-1031.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Case Report

Publication Date

July 6, 2015

Submission Date

May 24, 2015

Acceptance Date

-

Published in Issue

Year 1970 Volume: 2 Number: 5

APA
Yenigun, E., Turgut, D., Alaguney, E., Ozturk, R., Piskinpasa, S., & Dede, F. (2015). “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated? Medical Science and Discovery, 2(5), 316-17. https://doi.org/10.17546/msd.09431
AMA
1.Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated? Med Sci Discov. 2015;2(5):316-17. doi:10.17546/msd.09431
Chicago
Yenigun, Ezgi, Didem Turgut, Erdem Alaguney, Ramazan Ozturk, Serhan Piskinpasa, and Fatih Dede. 2015. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2 (5): 316-17. https://doi.org/10.17546/msd.09431.
EndNote
Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F (July 1, 2015) “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated? Medical Science and Discovery 2 5 316–17.
IEEE
[1]E. Yenigun, D. Turgut, E. Alaguney, R. Ozturk, S. Piskinpasa, and F. Dede, ““Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?”, Med Sci Discov, vol. 2, no. 5, pp. 316–17, July 2015, doi: 10.17546/msd.09431.
ISNAD
Yenigun, Ezgi - Turgut, Didem - Alaguney, Erdem - Ozturk, Ramazan - Piskinpasa, Serhan - Dede, Fatih. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2/5 (July 1, 2015): 316-17. https://doi.org/10.17546/msd.09431.
JAMA
1.Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated? Med Sci Discov. 2015;2:316–17.
MLA
Yenigun, Ezgi, et al. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery, vol. 2, no. 5, July 2015, pp. 316-17, doi:10.17546/msd.09431.
Vancouver
1.Ezgi Yenigun, Didem Turgut, Erdem Alaguney, Ramazan Ozturk, Serhan Piskinpasa, Fatih Dede. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated? Med Sci Discov. 2015 Jul. 1;2(5):316-17. doi:10.17546/msd.09431